For a complete list of references please email Dr. Smith: email@example.com.
1. , , et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994; 331: 1105–9.
2. , , , et al. Prehospital intravenous fluid administration is associated with higher mortality in trauma patients: a National Trauma Data Bank analysis. Ann Surg 2011; 253: 371–7.
3. , , , et al. Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma 2011; 70: 398–400.
4. , , , et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma 2011; 70: 652–63.
5. , , , et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011; 254: 598–605.
, , . Management of bleeding and coagulopathy following major trauma: an updated European guideline
. Critical Care 2013
(accessed July 2014).
7. , , . Compatibility of packed erythrocytes and Ringer’s lactate solution. Surg Gynecol Obstet 1991; 173: 9–12.
8. , , , et al. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort tudy. Anesth Analg 2013; 117: 412–21.
9. , , . Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001; 29): 489–93.
10. , , , In vivo investigation into the effects of haemodilution with hydroxyetil starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80: 612–16.
11. , , . Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery.Br J Anaesth 2002; 89: 226–30.
12. . Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med 2009; 360: 1283–97.
13. . Equivalent Efficacy of Hydroxyethyl Starch 130/0.4 and Human Serum Albumin: If Nothing Is the Same, Is Everything Different? The Importance of Context in Clinical Trials and Statistics. Anesthesiology 2013; 119: 1249–54.
15. , , , et al.; European Society of Intensive Care Medicine. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients.Intensive Care Med 2012; 38: 368–83.
16. , , , et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med 2012; 40: 2543–51.
17. , , . Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 2013; 11: 123–30
18. , , , . Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003; 123: 1853–7.
19. , , , et al. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998; 317: 235–40.
20. , . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012; (6): CD000567.
21. , , , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247–56.
22. , , , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357: 874–84.
23. , , , et al.; HTS Study Investigators. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004; 291: 1350–7.
24. , , , et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31: 1683–7.
25. , , , et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000; 28: 1144–51.
26. , , , et al. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma 1997; 42 (Supplement): 61S–65S.
27. , , , . Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2004; (3): CD002045.
28. , , , et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial JAMA. 2010; 304: 1455–64.
29. , , , et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 2011; 253: 431–41.
30. . Evidence-based transfusion medicine: TRICC & BART revisited. Blood Day, Winnipeg, November 4th, 2009.
31. , , , . Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42: 812–18.
32. , , et al. Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol 2005; 116: 1028–32.
33. , , , et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217–21.
34. , . What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah’s Witnesses. Transfusion 1994; 34: 396–401
35. , , , et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997; 96 (9 Suppl): II-194–9.
36. , , , et al. Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology 2004; 100: 70–6.
37. , , , et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 2002; 96: 871–7.
38. , , , et al. The influence of allogenic red blood cell transfusion compared with 100% oxygen ventilation on systemic oxygen transport and skeletal muscle oxygen tension after cardiac surgery. Anesth Analg 2004; 40: 457–60.
39. , . Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024–9.
40. , , , et al. Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med 2012; 172: 1154–60.
41. , , , et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544–52.
42. , , , , . Transfusions in burn patients with/without comorbidities. J Burn Care Res 2009; 30: 268–73.
43. , , . Evaluation of skin graft take following post-burn raw area in normovolaemic anaemia. Indian J Plast Surg 2009; 42: 195–8.
44. , , . The prevalence of perioperative visual loss in the United States: a 10-year study from 1996 to 2005 of spinal, orthopedic, cardiac, and general surgery. Anesth Analg 2009; 109: 1534–45.
45. , , , et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409–17.
46. , , , et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 2004; 57: 563–8.
47. , , , et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227–34.
48. , , , et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609–19.
49. , , , et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559–67.
50. , , , et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol 2011; 108: 1108–11.
51. , , . Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; (4): CD002042.
52. , , , et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555–62.
53. , . Is blood transfusion harmful in patients with acute coronary syndromes? CMAJ 2005; 172: 182.
54. , , , , . Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med 2013; 173: 132–9.
55. . Practice guidelines for perioperative blood transfusion and adjuvant therapies. An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198–208.
56. , , , et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65: 748–54.
57. , , , et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg 2010; 251: 604–14.
59. , , , , . Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resus Emerg Med 2012; 20: 15.
60. , , , . Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 1995; 80: 336.
61. , . Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991; 96: 770.
62. , , . Perioperative factor concentrate therapy. Br J Anaesth 2013; 11: i35–49.
63. , , , et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 8–15.
64. , , , . Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma 2007; 62: 1095–9
65. , , , et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage J Trauma 2010; 69: 489–500.
66. , , , . Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791–800.
67. , , , et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012; (3): CD005011.
68. , , . Massive transfusion protocols for patients with substantial hemorrhage. Transfus Med Rev 2011; 25: 293–303.
69. , , , et al. Defining when to initiate massive transfusion: a validation study of individual massive transfusion triggers in PROMMTT patients. J Trauma Acute Care Surg 2013; 74: 59–65, 67–8.
70. , , , . Comparison of massive blood transfusion predictive models in the rural setting. J Trauma Acute Care Surg 2012; 72: 211–15.
71. , , , et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003; 54: 898–905.
72. 3rd, , , et al. Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. J Trauma 2005; 58: 437–44.
73. , , , et al. Predictive factors of morbidity and mortality in grade IV and V liver trauma undergoing perihepatic packing: single institution 14 years experience at European trauma centre. Injury 2012; 43: 1347–54.
74. , , , et al. Role of anemia in traumatic brain injury. J Am Coll Surg 2008; 207: 398–406.
75. , , , et al.; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499–507.
76. , , , et al. The CRIT Study. Anemia and blood transfusion in the critically ill: current clinical practice in the United States. Crit Care Med 2004; 32: 39–52.
77. , , , et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49–55.
78. , , , et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997; 63: 964–7.
79. , , , , . Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003; 54: 908–14.
80. , , , . Duration of red cell storage before transfusion and in-hospital mortality. Am Heart J 2010; 159: 737–43.
81. , , , et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229–39.
82. , , , et al. Erythrocyte storage duration is not associated with increased mortality in noncardiac surgical patients: a retrospective analysis of 6,994 patients. Anesthesiology 2013; 118: 51–8.
83. , , , et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 2006; 104: 911–20.
84. , , , et al. Fresh and stored red blood cell transfusion equivalently induce subclinical pulmonary gas exchange deficit in normal humans. Anesth Analg 2012; 114: 511–19.
87. , , . Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004; 70: 15–28.